Venus Concept Inc. (NASDAQ:VERO – Get Free Report) was the target of a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 1,450,000 shares, an increase of 1,956.7% from the October 15th total of 70,500 shares. Approximately 35.1% of the shares of the company are sold short. Based on an average daily volume of 1,690,000 shares, the days-to-cover ratio is presently 0.9 days.
Venus Concept Stock Down 2.7 %
Shares of VERO traded down $0.01 during mid-day trading on Tuesday, hitting $0.39. The company’s stock had a trading volume of 3,739 shares, compared to its average volume of 1,118,227. The firm has a market capitalization of $2.84 million, a price-to-earnings ratio of -0.05 and a beta of 0.57. The company’s 50-day moving average is $0.51 and its 200-day moving average is $0.61. Venus Concept has a 52-week low of $0.33 and a 52-week high of $2.22. The company has a current ratio of 1.99, a quick ratio of 1.30 and a debt-to-equity ratio of 9.72.
Venus Concept (NASDAQ:VERO – Get Free Report) last issued its earnings results on Tuesday, August 13th. The company reported ($1.39) EPS for the quarter. The company had revenue of $16.58 million during the quarter. On average, equities research analysts forecast that Venus Concept will post -6.37 EPS for the current fiscal year.
Insider Buying and Selling at Venus Concept
Hedge Funds Weigh In On Venus Concept
A hedge fund recently raised its stake in Venus Concept stock. Masters Capital Management LLC boosted its position in Venus Concept Inc. (NASDAQ:VERO – Free Report) by 100.0% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 666,702 shares of the company’s stock after purchasing an additional 333,366 shares during the quarter. Masters Capital Management LLC owned about 10.49% of Venus Concept worth $522,000 at the end of the most recent reporting period. Institutional investors own 87.41% of the company’s stock.
About Venus Concept
Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
Recommended Stories
- Five stocks we like better than Venus Concept
- What Does a Stock Split Mean?
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Investing in the High PE Growth Stocks
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- Why Are These Companies Considered Blue Chips?
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.